Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma ; volume:11 ; number:1 ; day:7 ; month:1 ; year:2014 ; pages:1 ; date:1.2014
Retrovirology ; 11, Heft 1 (7.1.2014), 1, 1.2014
- Creator
-
Utsunomiya, Atae
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-11-S1-O3
- URN
-
urn:nbn:de:1111-2016080733897
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Utsunomiya, Atae
- SpringerLink (Online service)
Other Objects (12)
Enteropathy Associated T-Cell Lymphoma
A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma
News on Peripheral T-cell lymphoma
Novel CD20 monoclonal antibodies for lymphoma therapy
Therapeutic challenges in peripheral T-cell lymphoma
Cutaneous T-Cell Lymphoma with Nasal Necrosis
Semi-allogeneic vaccine for T-cell lymphoma
Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis
Pelger-Huët anomaly and T-cell lymphoma
Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
Endoscopic findings of enteropathy-type T-cell lymphoma
Novel therapeutic agents for cutaneous T-Cell lymphoma
Enteropathy Associated T-Cell Lymphoma
A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma
News on Peripheral T-cell lymphoma
Novel CD20 monoclonal antibodies for lymphoma therapy
Therapeutic challenges in peripheral T-cell lymphoma
Cutaneous T-Cell Lymphoma with Nasal Necrosis
Semi-allogeneic vaccine for T-cell lymphoma
Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis
Pelger-Huët anomaly and T-cell lymphoma
Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
Endoscopic findings of enteropathy-type T-cell lymphoma
Novel therapeutic agents for cutaneous T-Cell lymphoma
Enteropathy Associated T-Cell Lymphoma
A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma
News on Peripheral T-cell lymphoma
Novel CD20 monoclonal antibodies for lymphoma therapy
Therapeutic challenges in peripheral T-cell lymphoma
Cutaneous T-Cell Lymphoma with Nasal Necrosis
Semi-allogeneic vaccine for T-cell lymphoma
Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis
Pelger-Huët anomaly and T-cell lymphoma
Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
Endoscopic findings of enteropathy-type T-cell lymphoma